Baclofen to prevent agitation in alcohol-addicted patients in the ICU: study protocol for a randomised controlled trial

scientific article published on 19 August 2016

Baclofen to prevent agitation in alcohol-addicted patients in the ICU: study protocol for a randomised controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1011889179
P356DOI10.1186/S13063-016-1539-2
P8608Fatcat IDrelease_u6wzyd4xsfci3b3kd4l5unefly
P932PMC publication ID4992221
P698PubMed publication ID27542731

P50authorVéronique SébilleQ57015586
Karim AsehnouneQ91728919
Fanny FeuilletQ114436134
P2093author name stringMickael Vourc'h
BACLOREA trial group
Pierre-Joachim Mahe
P2860cites workBrain shrinkage in alcoholics: a decade on and what have we learned?Q33658092
Alcohol screening scores and 90-day outcomes in patients with acute lung injuryQ33723496
Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepamQ33993651
Alcohol-attributable mortality in FranceQ34035895
Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unitQ34313233
Sleep disturbances in the wake of traumatic eventsQ34467534
Alcohol as a risk factor for brain damage: neurologic aspectsQ34478345
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled studyQ34722965
Sample size recalculation in internal pilot study designs: a reviewQ36593600
Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older populationQ37238321
Anticipating and managing postoperative delirium and cognitive decline in adultsQ37903162
A prospective study of delirium in hospitalized elderlyQ40764917
Delirium tremens: a reviewQ40782116
Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.Q42640821
At-risk drinking is independently associated with ICU and one-year mortality in critically ill nontrauma patients*.Q43441882
Postoperative morbidity among symptom-free alcohol misusersQ43956696
The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methods.Q44824453
Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patientsQ46880812
Chronic alcoholism increases the induction dose of propofolQ48213371
Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.Q51001303
Influence of alcohol on anesthetic requirements and acute toxicity.Q51873026
Delirium. The occurrence and persistence of symptoms among elderly hospitalized patientsQ52045518
Alcohol as a Risk Factor for Brain Damage: Neurologic AspectsQ56227761
Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled TrialQ63464422
Epidemiologic study of anesthesia complications in FranceQ70337766
Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tractQ71604425
The new practice guidelines for pain, agitation, and deliriumQ86255429
P433issue1
P921main subjectstudy protocolQ111908491
P304page(s)415
P577publication date2016-08-19
P1433published inTrialsQ7840023
P1476titleBaclofen to prevent agitation in alcohol-addicted patients in the ICU: study protocol for a randomised controlled trial
P478volume17

Reverse relations

cites work (P2860)
Q38617705Baclofen for alcohol withdrawal.
Q92802451Pharmacokinetic data on high dose baclofen administration in unhealthy alcohol user in the ICU

Search more.